87 related articles for article (PubMed ID: 6379114)
1. Staphylococcal protein A in neoplastic disease.
Terman DS
J Biol Response Mod; 1984; 3(3):316-24. PubMed ID: 6379114
[No Abstract] [Full Text] [Related]
2. Clinical trials with Staphylococcus aureus and protein A in the treatment of malignant disease.
Messerschmidt GL; Bowles CA; Henry DH; Deisseroth AB
J Biol Response Mod; 1984; 3(3):325-9. PubMed ID: 6379115
[TBL] [Abstract][Full Text] [Related]
3. Perfusion of plasma over Staphylococcus aureus: release of bacterial products is related to regression of tumor.
Gordon BR; Matus RE; Hurvitz AI; MacEwen EG; Saal SD; Stenzel KH; Rubin AL; Hyden H
J Biol Response Mod; 1984; 3(3):266-70. PubMed ID: 6379111
[No Abstract] [Full Text] [Related]
4. Clinical experiences with extracorporeal immunoperfusion of plasma from cancer patients.
Korec S; Smith FP; Schein PS; Phillips TM
J Biol Response Mod; 1984; 3(3):330-5. PubMed ID: 6379116
[TBL] [Abstract][Full Text] [Related]
5. Clinical response to protein a-treated plasma infusions and in vitro correlation.
MacKintosh FR; Bennett K; Hall SW
J Biol Response Mod; 1984; 3(3):336-40. PubMed ID: 6379117
[No Abstract] [Full Text] [Related]
6. Experience with Staphylococcus aureus and protein A in the treatment of canine malignancies.
Bowles CA; Messerschmidt G; Deisseroth AB
J Biol Response Mod; 1984; 3(3):260-5. PubMed ID: 6379110
[No Abstract] [Full Text] [Related]
7. The use of Protein-A in the treatment of malignancy: rationale and the NCI experience.
Messerschmidt GL; Bowles C; Parrillo J; Parker M; Shelhammer J; Dowling R; Osborne L; Corbitt R; McCormack K; Longo D; Deisseroth A
Prog Clin Biol Res; 1982; 106():385-90. PubMed ID: 6757952
[No Abstract] [Full Text] [Related]
8. Cancer treatment with Staphylococcus aureus protein A.
Solal-Celigny P; Simeon J; Herrera A; Boivin P
Biomed Pharmacother; 1985; 39(4):177-86. PubMed ID: 3904855
[TBL] [Abstract][Full Text] [Related]
9. The use of protein A and concanavalin A to examine the possible role of the carbohydrate of IgG in the binding of Clq.
van Schravendijk MR; Dwek RA
Mol Immunol; 1981 Dec; 18(12):1079-85. PubMed ID: 6977701
[No Abstract] [Full Text] [Related]
10. [Clq binding activity of monomeric IgG].
Uwatoko S; Aotsuka S; Okawa M; Yokohari R; Aizawa C; Suzuki K
Arerugi; 1982 Oct; 31(10):1022-8. PubMed ID: 6984822
[No Abstract] [Full Text] [Related]
11. A trial of autologous plasma perfusion over protein A in patients with breast cancer.
Fer MF; Beman J; Stevenson HC; Maluish A; Moratz C; Delawter T; Foon K; Herberman RB; Oldham RK; Terman DS
J Biol Response Mod; 1984; 3(3):352-8. PubMed ID: 6235326
[No Abstract] [Full Text] [Related]
12. Effect of frequency of plasma adsorption over protein A-containing Staphylococcus aureus on regression of rat mammary adenocarcinomas: modification of antitumor immune response and tumor histopathology.
Ray PK; Mohammed J; Allen P; Raychaudhuri S; Dohadwala M; Bandyopadhyay S; Mark R
J Biol Response Mod; 1984; 3(1):39-59. PubMed ID: 6707699
[TBL] [Abstract][Full Text] [Related]
13. Perfusion of canine serum over Staphylococcus aureus Cowan 1: Evidence for release of protein A and changes in specific antibody activity.
Balint J; Jones FR
Immunol Commun; 1983; 12(6):573-91. PubMed ID: 6609117
[TBL] [Abstract][Full Text] [Related]
14. Interaction of human platelets with particle-adherent aggregated IgG: description of the experimental system and role of C1q and monomeric IgG.
Vollertsen RS; McDuffie FC; Bowie EJ
Clin Exp Immunol; 1983 May; 52(2):423-9. PubMed ID: 6602680
[TBL] [Abstract][Full Text] [Related]
15. Adsorption of plasma from tumor-bearing hosts over protein A--containing nonviable Staphylococcus aureus Cowan I: possible mechanism of antitumor reactions.
Ray PK; McLaughlin D; Allen P; Bandyopadhyay S; Idiculla A; Clarke L; Mark R; Rhoads JE; Bassett JG; Cooper DR
J Biol Response Mod; 1984; 3(3):293-302. PubMed ID: 6379112
[TBL] [Abstract][Full Text] [Related]
16. A high molecular weight protein from Staphylococcus intermedius cross-reacts with Staphylococcus aureus enterotoxin antibodies.
Laffan JJ; Petras P; Ferguson KP; Lambe DW
Microbios; 1996; 88(357):237-51. PubMed ID: 9178533
[TBL] [Abstract][Full Text] [Related]
17. Detection of immune complexes in serum of dogs with neoplastic disease by solid-phase C1q binding, using an enzyme-linked immunosorbent assay.
DeBoer DJ; Madewell BR
Am J Vet Res; 1983 Sep; 44(9):1710-3. PubMed ID: 6605101
[TBL] [Abstract][Full Text] [Related]
18. A sandwich ELISA method for detection of Staphylococcus aureus enterotoxins.
Berdal BP; Olsvik O; Omland T
Acta Pathol Microbiol Scand B; 1981 Dec; 89(6):411-5. PubMed ID: 7336927
[TBL] [Abstract][Full Text] [Related]
19. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
Langone JJ; Das C; Bennett D; Terman DS
J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcal cell membrane antigen, a possible antigen in post-methicillin resistant Staphylococcus aureus (MRSA) infection nephritis and IgA nephropathy, exhibits high immunogenic activity that is enhanced by superantigen.
Shimizu Y; Sakurai H; Hirayama K; Seki M; Yoh K; Yamagata K; Koyama A
J Nephrol; 2005; 18(3):249-56. PubMed ID: 16013011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
